Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ark Therapeutics Group PLC

www.arktherapeutics.com

Latest From Ark Therapeutics Group PLC

Stockwatch: Damage Not Controlled

As financial turmoil broke out around the world in the wake of the vote for Brexit, UK pharma majors GlaxoSmithKline and AstraZeneca saw their stock rise. There's an uncertain outlook for the broader life sciences sector.

Brexit Companies

Stockwatch: UniQure's guile and the dubious promise of gene therapy

After last week's headline-grabbing deal between Bristol Myers Squibb (BMS) and Dutch gene therapy company uniQure (scripintelligence.com, 6 April 2015), who would have thought that events in Europe might by the end of the week spell the demise of uniQure's gene therapy platform?

Cardiovascular Cancer

5 questions for biotech legend Sir Chris Evans

China

Will a pharma-shaped pin burst the biotech bubble?

This year, a combination of elements has combined to create a meteoric rise in biotech fortunes. But how long will it last? And will H2 see a reversal of riches? Andy Smith explores the inside of the biotech bubble.

Cancer Orthopedics
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
  • In Vitro Diagnostics
  • Medical Devices
    • Biomaterials
  • Pharmaceuticals
    • Drug Delivery
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Eurogene Ltd.
  • Ark Therapeutics Ltd.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Ark Therapeutics Group PLC
  • Senior Management
  • Martyn D Williams, CEO
  • Contact Info
  • Ark Therapeutics Group PLC
    Phone: (44) 20 7388 7722
    79 New Cavendish St.
    London, W1W 6XB
    UK
UsernamePublicRestriction

Register